Advancing New Standards in Reproductive Health (ANSIRH), Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, California; John Snow, Inc, Arlington, Virginia; and Ibis Reproductive Health, Oakland, California. Ms. Zlidar is currently at the Public Health Institute, Washington, DC.
Obstet Gynecol. 2015 Jan;125(1):175-183. doi: 10.1097/AOG.0000000000000603.
To conduct a retrospective observational cohort study to estimate the abortion complication rate, including those diagnosed or treated at emergency departments (EDs).
Using 2009-2010 abortion data among women covered by the fee-for-service California Medicaid program and all subsequent health care for 6 weeks after having an abortion, we analyzed reasons for ED visits and estimated the abortion-related complication rate and the adjusted relative risk. Complications were defined as receiving an abortion-related diagnosis or treatment at any source of care within 6 weeks after an abortion. Major complications were defined as requiring hospital admission, surgery, or blood transfusion.
A total of 54,911 abortions among 50,273 fee-for-service Medi-Cal beneficiaries were identified. Among all abortions, 1 of 16 (6.4%, n=3,531) was followed by an ED visit within 6 weeks but only 1 of 115 (0.87%, n=478) resulted in an ED visit for an abortion-related complication. Approximately 1 of 5,491 (0.03%, n=15) involved ambulance transfers to EDs on the day of the abortion. The major complication rate was 0.23% (n=126, 1/436): 0.31% (n=35) for medication abortion, 0.16% (n=57) for first-trimester aspiration abortion, and 0.41% (n=34) for second-trimester or later procedures. The total abortion-related complication rate including all sources of care including EDs and the original abortion facility was 2.1% (n=1,156): 5.2% (n=588) for medication abortion, 1.3% (n=438) for first-trimester aspiration abortion, and 1.5% (n=130) for second-trimester or later procedures.
Abortion complication rates are comparable to previously published rates even when ED visits are included and there is no loss to follow-up.
II.
开展一项回顾性观察队列研究,以估计堕胎并发症发生率,包括在急诊科(ED)诊断或治疗的病例。
利用 2009-2010 年加州医疗补助按服务付费计划覆盖的女性堕胎数据以及堕胎后 6 周内的所有后续医疗保健数据,我们分析了 ED 就诊的原因,并估计了堕胎相关并发症发生率和调整后的相对风险。并发症定义为在堕胎后 6 周内任何医疗来源接受与堕胎相关的诊断或治疗。主要并发症定义为需要住院、手术或输血。
在 50273 名按服务付费 Medi-Cal 受益人中,共确定了 54911 例堕胎。在所有堕胎中,有 1 例(6.4%,n=3531)在堕胎后 6 周内到 ED 就诊,但只有 1 例(0.87%,n=478)因堕胎相关并发症而到 ED 就诊。大约每 5491 例中有 1 例(0.03%,n=15)涉及在堕胎当天用救护车转至 ED。主要并发症发生率为 0.23%(n=126,1/436):药物流产为 0.31%(n=35),第一孕期吸引流产为 0.16%(n=57),第二孕期或更晚流产为 0.41%(n=34)。包括 ED 和最初堕胎机构在内的所有医疗来源的总堕胎相关并发症发生率为 2.1%(n=1156):药物流产为 5.2%(n=588),第一孕期吸引流产为 1.3%(n=438),第二孕期或更晚流产为 1.5%(n=130)。
即使包括 ED 就诊和无失访情况,堕胎并发症发生率与先前发表的发生率相当。
II 级。